Portal Hypertension Completed Phase 4 Trials for Terlipressin (DB02638)

Also known as: Hypertension Portal / Hypertension, Portal / Portal hypertensions

IndicationStatusPhase
DBCOND0029015 (Portal Hypertension)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00369694Short Course Terlipressin for Control of Acute Variceal BleedingTreatment
NCT00534677The Safety & Efficacy of Terlipressin vs Octreotide for the Control of Variceal BleedTreatment